MedPath

Veridation research of colonoscopy using artificial intelligence

Not Applicable
Conditions
colo-rectal adenoma or cancer
Registration Number
JPRN-UMIN000047666
Lead Sponsor
Foundation for detection of early gastric carcinoma
Brief Summary

The ADR was 59.4% in the CADe group and 47.6% in the control group (p = 0.018). The AMRrs was 11.9% in the CADe group and 26.0% in the control group (p = 0.037). The colonoscopy with the CADe system yielded an 11.8% higher ADR than that performed by experienced endoscopists alone. Moreover, there was no need to extend the examination time or request the assistance of additional medical staff to achieve this improved effectiveness.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
415
Inclusion Criteria

Not provided

Exclusion Criteria

After colorectal surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adenoma detection rate in total colonoscopy
Secondary Outcome Measures
NameTimeMethod
Adenoma miss rate in recto-sigmoid scopy
© Copyright 2025. All Rights Reserved by MedPath